⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Conserved Longevity Pathways Across Species
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-29 — Direct Pharmacological Activation of AMPK Extends Lifespan in Yeast, Worms and Flies: cross-connection with mtor-nutrient-sensing: Direct AMPK activators extending lifespan across yeast, worms, and flies place AMPK alongside mTOR/IIS as a confirmed conserved cross-phylum longevity lever, not just a correlate of CR. (novelty: 3)
- 2026-07-12 — Biological limits of lifespan extension: Evidence for a shift from pathway leverage to system-level buffering across species.: cross-connection with lifespan-extension-biological-limits: Review explicitly argues the conserved-pathway catalog (IIS, TOR, sirtuins, AMPK) delivers decreasing lifespan leverage as organismal complexity rises, directly tying the two pages’ claims. (novelty: 3)
- 2026-08-31 — A cross-species drug-discovery platform to accelerate the identification of lifespan-extending interventions.: Five-species (yeast, C. elegans, Drosophila, killifish, mouse) high-throughput screen of 400+ compounds identifies multi-species geroprotectors converging on conserved longevity pathways; methods-focused preclinical platform paper, no named human-translated hits in abstract. [animal-model] (novelty: 4)
Open questions
Related
Contributing findings
A cross-species drug-discovery platform to accelerate the identification of lifespan-extending interventions.
31-aug-2026
novelty 4
per-area 4
strengthens